The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey
Open accessAbstract
Autosomal dominant deficiency of signal transducer and activator of transcription 3 (STAT3) is the main genetic etiology of hyper-immunoglobulin (Ig) E syndrome. We documented the molecular, cellular, and clinical features of 60 patients with heterozygous STAT3 mutations from 47 kindreds followed in France. We identified 11 known and 13 new mutations of STAT3. Low levels of interleukin (IL)-6-dependent phosphorylation and nuclear translocation (or accumulation) of STAT3 were observed in Epstein-Barr virus-transformed B lymphocytes (EBV-B cells) from all STAT3-deficient patients tested. The immunologic phenotype was characterized by high serum IgE levels (96% of the patients), memory B-cell lymphopenia (94.5%), and hypereosinophilia (80%). A low proportion of IL-17A-producing circulating T cells was found in 14 of the 15 patients tested. Mucocutaneous infections were the most frequent, typically caused by Staphylococcus aureus (all patients) and Candida albicans (85%). Up to 90% of the patients had pneumonia, mostly caused by Staph. aureus (31%) or Streptococcus pneumoniae (30%). Recurrent pneumonia was associated with secondary bronchiectasis and pneumatocele (67%), as well as secondary aspergillosis (22%). Up to 92% of the patients had dermatitis and connective tissue abnormalities, with facial dysmorphism (95%), retention of decidual teeth (65%), osteopenia (50%), and hyperextensibility (50%). Four patients developed non-Hodgkin lymphoma. The clinical outcome was favorable, with 56 patients, including 43 adults, still alive at the end of study (mean age, 21 yr; range, 1 mo to 46 yr). Only 4 patients died, 3 from severe bacterial infection (aged 1, 15, and 29 yr, respectively). Antibiotic prophylaxis (90% of patients), antifungal prophylaxis (50%), and IgG infusions (53%) improved patient health, as demonstrated by the large decrease in pneumonia recurrence. Overall, the prognosis of STAT3 deficiency may be considered good, provided that multiple prophylactic measures, including IgG infusions, are implemented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citationProfessor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,221
The JAK-STAT Signaling Pathway: Input and Output Integration
Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2623 · Cited by 1,179
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064 · cited 1×
“albicans infection, [16] several groups have shown that IL-17-producing Tcell lymphopenia occurs in STAT3-deficient patients.”
BackgroundChronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 1×
“[56-58] Moreover, we recently found gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis.”
BackgroundSelf-citationDominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 1,048
Cytokine Signaling Modules in Inflammatory Responses
O'Shea, J. J., & Murray, P. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.002 · Cited by 818
Hyper-IgE Syndrome with Recurrent Infections — An Autosomal Dominant Multisystem Disorder
Grimbacher, B., Holland, S. M., Gallin, J. I., Greenberg, F., Hill, S. C., Malech, H. L., Miller, J. A., O'Connell, A. C., & Puck, J. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400904 · Cited by 803
Liu, L., Okada, S., Kong, X.-F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110958 · Cited by 797
Self-citationPuel, A., Döffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A., Ouachée-Chardin, M., Toulon, A., Bustamante, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091983 · Cited by 733
Self-citationSTAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A. B., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A. J., Smits-van der Graaf, C. A. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100102 · Cited by 666
Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Ma, C. S., Chew, G. Y. J., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., & Cook, M. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080218 · Cited by 652
Davis, S., Schaller, J., Wedgwood, R., & Harvard, M. D. (1966) · The Lancet · doi:10.1016/s0140-6736(66)90119-x · Cited by 609
EXTREME HYPERIMMUNOGLOBULINEMIA E AND UNDUE SUSCEPTIBILITY TO INFECTION
Buckley, R. H., Wray, B. B., & Belmaker, E. Z. (1972) · Pediatrics · doi:10.1542/peds.49.1.59 · Cited by 607
Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells
de Beaucoudrey, L., Puel, A., Filipe-Santos, O., Cobat, A., Ghandil, P., Chrabieh, M., Feinberg, J., von Bernuth, H., Samarina, A., Jannière, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080321 · Cited by 439
Self-citationClinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Picard, C., von Bernuth, H., Ghandil, P., Chrabieh, M., Levy, O., Arkwright, P. D., McDonald, D., Geha, R. S., Takada, H., Krause, J. C., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181fd8ec3 · Cited by 426
Self-citationAvery, D. T., Deenick, E. K., Ma, C. S., Suryani, S., Simpson, N., Chew, G. Y., Chan, T. D., Palendira, U., Bustamante, J., Boisson-Dupuis, S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091706 · Cited by 409
Self-citationGenetic Linkage of Hyper-IgE Syndrome to Chromosome 4
Grimbacher, B., Schäffer, A. A., Holland, S. M., Davis, J., Gallin, J. I., Malech, H. L., Atkinson, T. P., Belohradsky, B. H., Buckley, R. H., Cossu, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302547 · Cited by 405
NEW PATHOLOGICAL INSTITUTE AT THE LONDON
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91233-x · Cited by 367
Renner, E. D., Rylaarsdam, S., Aňover-Sombke, S., Rack, A. L., Reichenbach, J., Carey, J. C., Zhu, Q., Jansson, A. F., Barboza, J., Schimke, L. F., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.037 · Cited by 338
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
Woellner, C., Gertz, E. M., Schäffer, A. A., Lagos, M., Perro, M., Glocker, E.-O., Pietrogrande, M. C., Cossu, F., Franco, J. L., Matamoros, N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.059 · Cited by 316
Ding, B. B., Yu, J. J., Yu, R. Y.-L., Mendez, L. M., Shaknovich, R., Zhang, Y., Cattoretti, G., & Ye, B. H. (2008) · Blood · doi:10.1182/blood-2007-04-087734 · Cited by 298
Hill, H., Quie, P., Pabst, H., Ochs, H., Clark, R., Klebanoff, S., & Wedgwood, R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91942-4 · Cited by 269
Grimbacher, B., Holland, S. M., & Puck, J. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00228.x · Cited by 262
Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., & Wasik, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.466 · Cited by 262
Minegishi, Y., Saito, M., Nagasawa, M., Takada, H., Hara, T., Tsuchiya, S., Agematsu, K., Yamada, M., Kawamura, N., Ariga, T., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082767 · Cited by 243
Abnormalities in the Regulation of Human IgE Synthesis
Buckley, R. H., & Becker, W. G. (1978) · Immunological Reviews · doi:10.1111/j.1600-065x.1978.tb01469.x · Cited by 241
Freeman, A. F., & Holland, S. M. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.01.005 · Cited by 220
STAT3 is constitutively activated in Hodgkin cell lines
Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., Heinrich, P. C., Diehl, V., & Tesch, H. (2001) · Blood · doi:10.1182/blood.v98.3.762 · Cited by 218
Nieminen, P., Morgan, N. V., Fenwick, A. L., Parmanen, S., Veistinen, L., Mikkola, M. L., van der Spek, P. J., Giraud, A., Judd, L., Arte, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.024 · Cited by 199
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
Bozec, A., Bakiri, L., Hoebertz, A., Eferl, R., Schilling, A. F., Komnenovic, V., Scheuch, H., Priemel, M., Stewart, C. L., Amling, M., et al. (2008) · Nature · doi:10.1038/nature07019 · Cited by 193
Dagoneau, N., Scheffer, D., Huber, C., Al-Gazali, L. I., Di Rocco, M., Godard, A., Martinovic, J., Raas-Rothschild, A., Sigaudy, S., Unger, S., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381715 · Cited by 190
Puel, A., Picard, C., Lorrot, M., Pons, C., Chrabieh, M., Lorenzo, L., Mamani-Matsuda, M., Jouanguy, E., Gendrel, D., & Casanova, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.647 · Cited by 188
Self-citationLife‐threatening infectious diseases of childhood: single‐gene inborn errors of immunity?
Alcaïs, A., Quintana‐Murci, L., Thaler, D. S., Schurr, E., Abel, L., & Casanova, J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05834.x · Cited by 181
Self-citationCauses of death in hyper-IgE syndrome
Freeman, A. F., Kleiner, D. E., Nadiminti, H., Davis, J., Quezado, M., Anderson, V., Puck, J. M., & Holland, S. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.666 · Cited by 172
Schimke, L. F., Sawalle-Belohradsky, J., Roesler, J., Wollenberg, A., Rack, A., Borte, M., Rieber, N., Cremer, R., Maaß, E., Dopfer, R., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.029 · Cited by 170
Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel, A., Pïcard, C., Cypowyj, S., Lilić, D., Abel, L., & Casanova, J. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.009 · Cited by 151
Self-citationSTAT3 is required for IL-21–induced secretion of IgE from human naive B cells
Avery, D. T., Ma, C. S., Bryant, V. L., Santner‐Nanan, B., Nanan, R. K. H., Wong, M., Fulcher, D. A., Cook, M., & Tangye, S. G. (2008) · Blood · doi:10.1182/blood-2008-02-142745 · Cited by 144
Minegishi, Y. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.013 · Cited by 131
Invasive fungal disease in autosomal-dominant hyper-IgE syndrome
Vinh, D. C., Sugui, J. A., Hsu, A. P., Freeman, A. F., & Holland, S. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.047 · Cited by 115
Hyperimmunoglobulin‐E syndrome with recurrent infection: A review of current opinion and treatment
Erlewyn‐Lajeunesse, M. (2000) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2000.00091.x · Cited by 103
Non-Hodgkin's Lymphoma in Job's Syndrome: A Case Report and Literature Review
Leonard, G., Posadas, E. M., Herrmann, P. C., Anderson, V., Jaffe, E. S., Holland, S. M., & Wilson, W. H. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400004463 · Cited by 101
Emmendörffer, A., Nakamura, M., Rothe, G., Spiekermann, K., Lohmann-Matthes, M. L., & Roesler, J. (1994) · Cytometry · doi:10.1002/cyto.990180306 · Cited by 96
Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome
O’Connell, A. C., Puck, J. M., Grimbacher, B., Facchetti, F., Majorana, A., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1067/moe.2000.103129 · Cited by 96
Clinical and Immunologic Aspects of the Hyperimmunoglobulin E Syndrome
Leung, D. Y. M., & Geha, S. (1988) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30632-4 · Cited by 95
Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups
Jiao, H., Tóth, B., Erdös, M., Fransson, I., Rákóczi, É., Balogh, I., Magyarics, Z., Dérfalvi, B., Csorba, G., Szaflarska, A., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.001 · Cited by 94
Reduced memory B cells in patients with hyper IgE syndrome
Speckmann, C., Enders, A., Woellner, C., Thiel, D., Rensing‐Ehl, A., Schlesier, M., Rohr, J., Jakob, T., Oswald, E., Kopp, M., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.002 · Cited by 82
STAT3Mutation in the Original Patient with Job's Syndrome
Renner, E. D., Torgerson, T. R., Rylaarsdam, S., Anover-Sombke, S. D., Golob, K., LaFlam, T. N., Zhu, Q., & Ochs, H. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmc076367 · Cited by 79
Chandesris, M., Azarine, A., Ong, K.-T., Taleb, S., Boutouyrie, P., Mousseaux, É., Romain, M., Bozec, E., Laurent, S., Boddaert, N., et al. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961235 · Cited by 79
Self-citationBorges, W. G., Hensley, T., Carey, J. C., Petrak, B. A., & Hill, H. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70243-4 · Cited by 78
Paulson, M. L., Freeman, A. F., & Holland, S. M. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283184210 · Cited by 77
Craniosynostosis in hyper-IgE-syndrome
Hoeger, P. H., Boltshauser, E., & Hitzig, W. H. (1985) · European Journal of Pediatrics · doi:10.1007/bf00441793 · Cited by 56
Sheerin, K. A., & Buckley, R. H. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90126-9 · Cited by 56
CRANIAL SYNOSTOSIS IN JOB'S SYNDROME
Smithwick, E. M., Finelt, M., Pahwa, S. G., Good, R. A., Naspitz, C. K., Mendes, N. F., Kopersztyck, S., Spira, T. J., & Nahmias, A. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)93028-3 · Cited by 54
Diffuse Large B Cell Lymphoma in Hyper-IgE Syndrome Due To STAT3 Mutation
Kumánovics, A., Perkins, S. L., Gilbert, H. M., Cessna, M. H., Augustine, N. H., & Hill, H. R. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9452-z · Cited by 50
Stüve–Wiedemann syndrome: long‐term follow‐up and genetic heterogeneity
Jung, C., Dagoneau, N., Baujat, G., Merrer, M. F. L., David, A., Rocco, M. D., Hamel, B. C. J., Mégarbané, A., Superti‐Furga, A., Unger, S., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01314.x · Cited by 38
Powers, A. E., Bender, J. M., Kumánovics, A., Ampofo, K., Augustine, N. H., Pavia, A. T., & Hill, H. R. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819866ec · Cited by 36
Papanastasiou, A. D., Mantagos, S. P., Papanastasiou, D. A., & Zarkadis, I. K. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.01.010 · Cited by 21
Kim, H., Kim, J., Shin, Y. K., Lee, S.-I., & Ahn, K. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.01.068 · Cited by 21
Hyper‐IgE Syndrome with STAT3 Mutation: A Case Report in Mainland China
Xie, L., Hu, X., Li, Y., Zhang, W., & Chen, L. (2010) · Journal of Immunology Research · doi:10.1155/2010/289873 · Cited by 16
Liu, J., Li, Q., Chen, T., Guo, X. N., Ge, J., & Yuan, L. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1349-6 · Cited by 16
Hyperimmunoglobulin E syndrome with a novel STAT3 mutation
Anolik, R., Elmariah, S. B., Lehrhoff, S., Votava, H. J., Martiniuk, F. T., & Levis, W. R. (2009) · Dermatology Online Journal · doi:10.5070/d31mt365wn · Cited by 11
Cited by
JAKs and STATs in immunity, immunodeficiency, and cancer
O'Shea, J. J., Holland, S. M., & Staudt, L. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1202117 · Cited by 927
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., Keller, M., Kobrynski, L. J., Komarow, H. D., Mazer, B., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.049 · Cited by 791
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
Toubiana, J., Okada, S., Hiller, J., Oleastro, M., Lagos Gomez, M., Aldave Becerra, J. C., Ouachée-Chardin, M., Fouyssac, F., Girisha, K. M., Etzioni, A., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679902 · Cited by 577
Self-citationImpairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
Okada, S., Markle, J. G., Deenick, E. K., Mele, F., Averbuch, D., Lagos, M., Alzahrani, M., Al-Muhsen, S., Halwani, R., Ma, C. S., et al. (2015) · Science · doi:10.1126/science.aaa4282 · Cited by 413
Self-citationHuman TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
Kreins, A. Y., Ciancanelli, M. J., Okada, S., Kong, X.-F., Ramírez-Alejo, N., Kilic, S. S., El Baghdadi, J., Nonoyama, S., Mahdaviani, S. A., Ailal, F., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140280 · Cited by 363
Self-citation
Metadata
- Authors
- Chandesris, M.-O., Melki, I., Natividad, A., Puel, A., Fieschi, C., Yun, L., Thumerelle, C., Oksenhendler, E., Boutboul, D., Thomas, C., Hoarau, C., Lebranchu, Y., Stephan, J.-L., Cazorla, C., Aladjidi, N., Micheau, M., Tron, F., Baruchel, A., Barlogis, V., Palenzuela, G., Mathey, C., Dominique, S., Body, G., Munzer, M., Fouyssac, F., Jaussaud, R., Bader-Meunier, B., Mahlaoui, N., Blanche, S., Debré, M., Le Bourgeois, M., Gandemer, V., Lambert, N., Grandin, V., Ndaga, S., Jacques, C., Harre, C., Forveille, M., Alyanakian, M.-A., Durandy, A., Bodemer, C., Suarez, F., Hermine, O., Lortholary, O., Casanova, J.-L., Fischer, A., & Picard, C.
- Venue
- Medicine
- Published
- 2012-07
- Volume
- 91
- Issue
- 4
- Pages
- e1-e19
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2061014664
- Cited by
- 335
- References
- 67
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.